Cargando…

Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis

INTRODUCTION: Epstein-Barr virus exposure appears to be an environmental trigger for rheumatoid arthritis that interacts with other risk factors. Relationships among anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status have been observed in patients with rheumatoid ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazbek, Michel Alexandre, de Barros-Mazon, Silvia, Rossi, Cláudio Lúcio, Londe, Ana Carolina, Costallat, Lilian Tereza Lavras, Bértolo, Manoel Barros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161219/
https://www.ncbi.nlm.nih.gov/pubmed/21915491
http://dx.doi.org/10.1590/S1807-59322011000800016
_version_ 1782210654324654080
author Yazbek, Michel Alexandre
de Barros-Mazon, Silvia
Rossi, Cláudio Lúcio
Londe, Ana Carolina
Costallat, Lilian Tereza Lavras
Bértolo, Manoel Barros
author_facet Yazbek, Michel Alexandre
de Barros-Mazon, Silvia
Rossi, Cláudio Lúcio
Londe, Ana Carolina
Costallat, Lilian Tereza Lavras
Bértolo, Manoel Barros
author_sort Yazbek, Michel Alexandre
collection PubMed
description INTRODUCTION: Epstein-Barr virus exposure appears to be an environmental trigger for rheumatoid arthritis that interacts with other risk factors. Relationships among anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status have been observed in patients with rheumatoid arthritis from different populations. OBJECTIVE: To perform an association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status in Brazilian patients with rheumatoid arthritis. METHODS: In a case-control study, 140 rheumatoid arthritis patients and 143 healthy volunteers who were matched for age, sex, and ethnicity were recruited. Anti-Epstein-Barr nuclear antigen-1 antibodies and anti-cyclic citrullinated peptide antibodies were examined using an enzyme-linked immunosorbent assay, and shared epitope alleles were identified by genotyping. Smoking information was collected from all subjects. A comparative analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status was performed in the patient group. Logistic regression analysis models were used to analyze the risk of rheumatoid arthritis. RESULTS: Anti-Epstein-Barr nuclear antigen-1 antibodies were not associated with anti-cyclic citrullinated peptide antibodies, shared epitope alleles, or smoking status. Anti-cyclic citrullinated peptide antibody positivity was significantly higher in smoking patients with shared epitope alleles (OR = 3.82). In a multivariate logistic regression analysis using stepwise selection, only anti-cyclic citrullinated peptide antibodies were found to be independently associated with rheumatoid arthritis (OR = 247.9). CONCLUSION: Anti-Epstein-Barr nuclear antigen-1 antibodies did not increase the risk of rheumatoid arthritis and were not associated with the rheumatoid arthritis risk factors studied. Smoking and shared epitope alleles were correlated with anti-cyclic citrullinated peptide-antibody-positive rheumatoid arthritis. Of the risk factors, only anti-cyclic citrullinated peptides antibodies were independently associated with rheumatoid arthritis susceptibility.
format Online
Article
Text
id pubmed-3161219
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-31612192011-08-29 Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis Yazbek, Michel Alexandre de Barros-Mazon, Silvia Rossi, Cláudio Lúcio Londe, Ana Carolina Costallat, Lilian Tereza Lavras Bértolo, Manoel Barros Clinics (Sao Paulo) Clinical Science INTRODUCTION: Epstein-Barr virus exposure appears to be an environmental trigger for rheumatoid arthritis that interacts with other risk factors. Relationships among anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status have been observed in patients with rheumatoid arthritis from different populations. OBJECTIVE: To perform an association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status in Brazilian patients with rheumatoid arthritis. METHODS: In a case-control study, 140 rheumatoid arthritis patients and 143 healthy volunteers who were matched for age, sex, and ethnicity were recruited. Anti-Epstein-Barr nuclear antigen-1 antibodies and anti-cyclic citrullinated peptide antibodies were examined using an enzyme-linked immunosorbent assay, and shared epitope alleles were identified by genotyping. Smoking information was collected from all subjects. A comparative analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status was performed in the patient group. Logistic regression analysis models were used to analyze the risk of rheumatoid arthritis. RESULTS: Anti-Epstein-Barr nuclear antigen-1 antibodies were not associated with anti-cyclic citrullinated peptide antibodies, shared epitope alleles, or smoking status. Anti-cyclic citrullinated peptide antibody positivity was significantly higher in smoking patients with shared epitope alleles (OR = 3.82). In a multivariate logistic regression analysis using stepwise selection, only anti-cyclic citrullinated peptide antibodies were found to be independently associated with rheumatoid arthritis (OR = 247.9). CONCLUSION: Anti-Epstein-Barr nuclear antigen-1 antibodies did not increase the risk of rheumatoid arthritis and were not associated with the rheumatoid arthritis risk factors studied. Smoking and shared epitope alleles were correlated with anti-cyclic citrullinated peptide-antibody-positive rheumatoid arthritis. Of the risk factors, only anti-cyclic citrullinated peptides antibodies were independently associated with rheumatoid arthritis susceptibility. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011-08 /pmc/articles/PMC3161219/ /pubmed/21915491 http://dx.doi.org/10.1590/S1807-59322011000800016 Text en Copyright © 2011 Hospital das Clínicas da FMUSP http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Science
Yazbek, Michel Alexandre
de Barros-Mazon, Silvia
Rossi, Cláudio Lúcio
Londe, Ana Carolina
Costallat, Lilian Tereza Lavras
Bértolo, Manoel Barros
Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis
title Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis
title_full Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis
title_fullStr Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis
title_full_unstemmed Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis
title_short Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis
title_sort association analysis of anti-epstein-barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in brazilian patients with rheumatoid arthritis
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161219/
https://www.ncbi.nlm.nih.gov/pubmed/21915491
http://dx.doi.org/10.1590/S1807-59322011000800016
work_keys_str_mv AT yazbekmichelalexandre associationanalysisofantiepsteinbarrnuclearantigen1antibodiesanticycliccitrullinatedpeptideantibodiesthesharedepitopeandsmokingstatusinbrazilianpatientswithrheumatoidarthritis
AT debarrosmazonsilvia associationanalysisofantiepsteinbarrnuclearantigen1antibodiesanticycliccitrullinatedpeptideantibodiesthesharedepitopeandsmokingstatusinbrazilianpatientswithrheumatoidarthritis
AT rossiclaudiolucio associationanalysisofantiepsteinbarrnuclearantigen1antibodiesanticycliccitrullinatedpeptideantibodiesthesharedepitopeandsmokingstatusinbrazilianpatientswithrheumatoidarthritis
AT londeanacarolina associationanalysisofantiepsteinbarrnuclearantigen1antibodiesanticycliccitrullinatedpeptideantibodiesthesharedepitopeandsmokingstatusinbrazilianpatientswithrheumatoidarthritis
AT costallatlilianterezalavras associationanalysisofantiepsteinbarrnuclearantigen1antibodiesanticycliccitrullinatedpeptideantibodiesthesharedepitopeandsmokingstatusinbrazilianpatientswithrheumatoidarthritis
AT bertolomanoelbarros associationanalysisofantiepsteinbarrnuclearantigen1antibodiesanticycliccitrullinatedpeptideantibodiesthesharedepitopeandsmokingstatusinbrazilianpatientswithrheumatoidarthritis